Market Overview:
DTx market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for digital therapeutics across different applications such as hospitals and clinics. Additionally, the growing awareness about the benefits of digital therapeutics is also contributing to the growth of this market. The global DTx market by type is segmented into software, services, and hardware. The software segment dominates this market with a share of XX%. This dominance can be attributed to factors such as rising adoption of software-based DTx solutions and growing demand for personalized medicine. The services segment is projected to grow at a CAGR of XX% during the forecast period from 2018 to 2030 owing to increasing demand for remote patient monitoring services and consulting services.
Product Definition:
DTx is a type of digital health intervention that is delivered through a software application or other digital platform. DTx interventions are designed to improve patient outcomes and/or reduce costs by providing patients with personalized feedback, support, and resources. The use of DTx interventions has been shown to be effective in the treatment of conditions such as anxiety, depression, diabetes, and heart disease.
Software:
Software is the collection of tools and techniques for carrying out a specific task. In case of digital therapeutics, software is used to store and retrieve patient health information from electronic medical records (EMR) using barcodes or QR codes.
Services:
The global services and it's usage in the digital therapeutic market size was valued at USD 1.1 billion in 2018 and is expected to grow at a compound annual growth rate (CAGR) of 19.7% from 2019 to 2023.
Application Insights:
Based on application, the global DTx market is segmented into hospitals, clinics and other healthcare facilities, and home care settings. The hospital segment dominated the overall industry in terms of revenue in 2017. This can be attributed to factors such as increasing patient admissions due to chronic diseases or injuries across the globe. For instance, according to WHO¢â‚¬â„¢s HealthSTAT Global Report 2018 published last year, around 1 billion people are admitted every year due to illnesses or injuries worldwide. Moreover, growing investments by governments for developing new diagnostic technologies and treatments will also boost demand over the forecast period.
The clinic/other healthcare facility segment is expected register a significant CAGR of XX% from 2018 to 2030 owing to an increase in investments for developing advanced software solutions that help practitioners manage their workflow more efficiently while improving clinical outcomes at reduced costs.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement policies, and rising healthcare expenditure are some of the factors contributing to its growth. In addition, increasing adoption of digital therapeutics in cancer care is expected to drive this regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to increasing awareness about advanced technologies such as digital therapy among patients and physicians as well as government support for improving healthcare infrastructure in emerging countries such as China and India. Moreover, growing investments by governments & private entities for developing novel software solutions will boost demand further over the coming years. For instance; ‘Make in India’ initiative undertaken by Indian government aims at manufacturing products within country which will create jobs & boost economic activity thereby driving innovation & development within medical devices sector which can be used for Digital Therapeutic purposes or not (Srinivasan et al., 2018).
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. According to the World Health Organization, chronic diseases account for 63% of all deaths worldwide. This number is expected to increase to 73% by 2030. The rising prevalence of chronic diseases is a major driver for the growth of the DTx market.
- Growing demand for personalized medicine: There is a growing demand for personalized medicine across the globe due to the increasing incidence of complex and rare diseases. Personalized medicine involves tailoring treatment regimens according to individual patient characteristics such as age, gender, and genetic makeup. This helps in achieving better outcomes and reducing adverse effects associated with traditional therapies. The growing demand for personalized medicine is a major driver for the growth of the DTx market
- Google’s parent company Alphabet announced that it will invest 0 million over five years into Verily Life Sciences (a subsidiary of Alphabet) to develop new digital therapeutics products aimed at treating various health conditions such as diabetes, heart disease, mental health disorders etc.). This increased funding towards research on digital therapeutics will help fuel its growth in future years .
Scope Of The Report
Report Attributes
Report Details
Report Title
Digital Therapeutic (DTx) Market Research Report
By Type
Software, Services, Hardware
By Application
Hospitals, Clinic
By Companies
Proteus Digital Health, Inc., Omada Health, Inc., Welldoc, Inc., Livongo Health, Noom Inc., Ginger.Io, Inc., Propeller Health (ResMed), 2morrow Inc., Happify, Kaia Health, Mango Health, Click Therapeutics, Canary Health, Wellthy Therapeutics, Cognoa, Ayogo Health, Mindstrong Health
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
126
Number of Tables & Figures
89
Customization Available
Yes, the report can be customized as per your need.
Global Digital Therapeutic (DTx) Market Report Segments:
The global Digital Therapeutic (DTx) market is segmented on the basis of:
Types
Software, Services, Hardware
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Proteus Digital Health, Inc.
- Omada Health, Inc.
- Welldoc, Inc.
- Livongo Health
- Noom Inc.
- Ginger.Io, Inc.
- Propeller Health (ResMed)
- 2morrow Inc.
- Happify
- Kaia Health
- Mango Health
- Click Therapeutics
- Canary Health
- Wellthy Therapeutics
- Cognoa
- Ayogo Health
- Mindstrong Health
Highlights of The Digital Therapeutic (DTx) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Software
- Services
- Hardware
- By Application:
- Hospitals
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Digital Therapeutic (DTx) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
DTx is a new type of healthcare delivery model that uses digital technology to improve the quality and efficiency of patient care. DTx can help reduce costs, improve patient satisfaction, and support population health goals.
Some of the major players in the digital therapeutic (dtx) market are Proteus Digital Health, Inc., Omada Health, Inc., Welldoc, Inc., Livongo Health, Noom Inc., Ginger.Io, Inc., Propeller Health (ResMed), 2morrow Inc., Happify, Kaia Health, Mango Health, Click Therapeutics, Canary Health, Wellthy Therapeutics, Cognoa, Ayogo Health, Mindstrong Health.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Digital Therapeutic (DTx) Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Digital Therapeutic (DTx) Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Digital Therapeutic (DTx) Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Digital Therapeutic (DTx) Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Digital Therapeutic (DTx) Market Size & Forecast, 2018-2028 4.5.1 Digital Therapeutic (DTx) Market Size and Y-o-Y Growth 4.5.2 Digital Therapeutic (DTx) Market Absolute $ Opportunity
Chapter 5 Global Digital Therapeutic (DTx) Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Digital Therapeutic (DTx) Market Size Forecast by Type
5.2.1 Software
5.2.2 Services
5.2.3 Hardware
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Digital Therapeutic (DTx) Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Digital Therapeutic (DTx) Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Digital Therapeutic (DTx) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Digital Therapeutic (DTx) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Digital Therapeutic (DTx) Analysis and Forecast
9.1 Introduction
9.2 North America Digital Therapeutic (DTx) Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Digital Therapeutic (DTx) Market Size Forecast by Type
9.6.1 Software
9.6.2 Services
9.6.3 Hardware
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Digital Therapeutic (DTx) Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Digital Therapeutic (DTx) Analysis and Forecast
10.1 Introduction
10.2 Europe Digital Therapeutic (DTx) Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Digital Therapeutic (DTx) Market Size Forecast by Type
10.6.1 Software
10.6.2 Services
10.6.3 Hardware
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Digital Therapeutic (DTx) Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Digital Therapeutic (DTx) Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Digital Therapeutic (DTx) Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Digital Therapeutic (DTx) Market Size Forecast by Type
11.6.1 Software
11.6.2 Services
11.6.3 Hardware
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Digital Therapeutic (DTx) Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Digital Therapeutic (DTx) Analysis and Forecast
12.1 Introduction
12.2 Latin America Digital Therapeutic (DTx) Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Digital Therapeutic (DTx) Market Size Forecast by Type
12.6.1 Software
12.6.2 Services
12.6.3 Hardware
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Digital Therapeutic (DTx) Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Digital Therapeutic (DTx) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Digital Therapeutic (DTx) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Digital Therapeutic (DTx) Market Size Forecast by Type
13.6.1 Software
13.6.2 Services
13.6.3 Hardware
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Digital Therapeutic (DTx) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Digital Therapeutic (DTx) Market: Competitive Dashboard
14.2 Global Digital Therapeutic (DTx) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Proteus Digital Health, Inc.
14.3.2 Omada Health, Inc.
14.3.3 Welldoc, Inc.
14.3.4 Livongo Health
14.3.5 Noom Inc.
14.3.6 Ginger.Io, Inc.
14.3.7 Propeller Health (ResMed)
14.3.8 2morrow Inc.
14.3.9 Happify
14.3.10 Kaia Health
14.3.11 Mango Health
14.3.12 Click Therapeutics
14.3.13 Canary Health
14.3.14 Wellthy Therapeutics
14.3.15 Cognoa
14.3.16 Ayogo Health
14.3.17 Mindstrong Health